TECHNIA AB

How the Foreign Office will promote Swedish life science exports

The broadness and innovative strength keep Swedish life science exports strong, but the protectionist tendencies in the world are worrying, says Camilla Melland...

Disappointment for Diamyd in Phase III – the share price plunges

Diamyd Medical’s share was sharply down on Monday following negative Phase III results. “This outcome is highly unexpected,” said the company’s CEO, Ulf Hannelius.

How MoniDose strengthened their regulatory confidence—fast

When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.

Nordic collaboration delivering the next leap in spatial biology

Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...

A tiny animal with great importance

From the mythical Ganges River to the less sacred, but considerably cleaner waters in KI's aquariums in Solna. The little zebrafish has made an unconscious care...

Important notification for IVDR Class C device manufacturers

Deadline for application is quickly approaching; 26 May 2026.

End of bone‑sawing? New laser cuts to record depths

Saw, drill and chisel are a bone surgeon’s best friends today – but soon the laser may also find its place in that toolbox. Researchers in Switzerland have disc...

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Paul Chaplin steps down as CEO of Bavarian Nordic

Danish vaccine company Bavarian Nordic’s CEO, Paul Chaplin, is stepping down from his position for personal reasons.

Automated high-speed scanning of probes

ZEISS Axioscan 7 spatial biology.

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

A cluster contribution to European life science innovation and competitiveness?

Networking event in Denmark: Sponsor Oversight in Clinical Trials

We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documen...

Supporting Investigator Initiated Clinical Studies—From Start to Finish

Many important clinical studies start with researchers – not pharmaceutical companies. In investigator initiated studies, pharmaceutical companies often support...

The art of successful licensing – “A lot has to align”

Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies...

Health politician Lina Nordquist: ”I find it hard to be idle”

She is the pharmacist and researcher who grew tired of the breakthroughs that never materialised and knowledge that never seemed to reach patients, so she decid...

New antibody aims to slow kidney damage – “It’s kind of cool”

For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.

Lost in the recruitment process? How hiring really works today

As recruitment becomes increasingly automated, candidates are expected to adapt to both human and algorithmic decision-making. Career coach Tina Persson outline...

More than 150 jobs cut as Merck scales back vaccin production

Merck & Co, known as MSD in Europe, is hitting the brakes following a sharp decline in demand for its HPV vaccine Gardasil. Production at its facility in Durham...

Novo Nordisk strengthens board after turbulent year

Changes to Novo Nordisk’s board continue. Following last year’s sweeping restructuring, the Danish obesity drugmaker is now nominating two new directors with ex...

Who pays for Rebecca Doe – and all of us?

Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it

New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows

Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.

Anna Törner: ”Drug prices – an important driver of innovation”

We live under the illusion that no price is too high when it comes to health, but that simply isn’t true, writes Anna Törner.